YJ1206, CAS [[3053716-98-3]]

Produktübersicht

• Artikelname: YJ1206, CAS [[3053716-98-3]]
• Artikelnummer: MCE-HY-168555
• Hersteller Artikelnummer: HY-168555
• Alternativnummer: MCE-HY-168555-10MMX1ML,MCE-HY-168555-10MG,MCE-HY-168555-5MG,MCE-HY-168555-100MG,MCE-HY-168555-50MG,MCE-HY-168555-25MG,MCE-HY-168555-1G,MCE-HY-168555-250MG,MCE-HY-168555-500MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

YJ1206 is an orally active selective CDK12/CDK13 PROTAC degrader. YJ1206 induces DNA damage and genomic instability, activates the AKT pathway, and triggers apoptosis. YJ1206 reduces tumor cell viability, inhibits tumor growth, and attenuates tumor cell dissemination. YJ1206 is applicable to research related to prostate cancer and high-grade serous tubo-ovarian cancer[1][2].

Produkteigenschaften

• Molekulargewicht: 894.01
• Reinheit: 96.92
• CAS Nummer: [3053716-98-3]
• Formel: C49H52FN11O5
• Target-Kategorie: Akt,Apoptosis,CDK,mTOR,PROTACs

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound